NPPB and hydrops fetalis: Analysis of cardiac biomarkers yielded higher median serum levels of NT-proBNP in PARAGON-HF-like patients (Cohort 1) as compared to Cohort 2, while patients in Cohort 3 showed the highest median serum levels of NT-proBNP (p < 0.001).